Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Menopausal Breast Cancer”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Testing effectiveness (Phase 2)UnknownNCT03906669
What this trial is testing

A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

Who this might be right for
Early-stage Breast CancerHormone Receptor Positive Tumor
St Vincent's Hospital 200
Post-approval studies (Phase 4)Study completedNCT05631795
What this trial is testing

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT02501031
What this trial is testing

Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women

Who this might be right for
Healthy
Cancer Care Ontario 99
Testing effectiveness (Phase 2)Ended earlyNCT01528345
What this trial is testing

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 97
Early research (Phase 1)Study completedNCT00099008
What this trial is testing

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Who this might be right for
Breast CancerEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02883985
What this trial is testing

Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers

Who this might be right for
Breast Cancer
NYU Langone Health 100
Not applicableStudy completedNCT06070155
What this trial is testing

Effect of Aerobic Exercises on Trace Elements in Post-menopausal Women After Radiotherapy

Who this might be right for
Trace Elements Levels After Breast Cancer Radiotherapy
Cairo University 28
Post-approval studies (Phase 4)Study completedNCT00688909
What this trial is testing

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 261
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00530868
What this trial is testing

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Who this might be right for
Breast CancerCancer of the BreastBreast Neoplasm
University of Alabama at Birmingham 75
Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069038
What this trial is testing

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Who this might be right for
Breast Cancer
University of Nebraska 51
Early research (Phase 1)Looking for participantsNCT07401381
What this trial is testing

Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Who this might be right for
Hormone Receptor Positive Early Breast Cancer
Rovi Pharmaceuticals Laboratories 120
Testing effectiveness (Phase 2)Ended earlyNCT00499681
What this trial is testing

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 6
Not applicableStudy completedNCT01951976
What this trial is testing

Yoga for Aromatase Inhibitor-associated Joint Pain

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT02729701
What this trial is testing

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

Who this might be right for
Breast Cancer
University of Kansas Medical Center 28
Not applicableStudy completedNCT01385280
What this trial is testing

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Cancer+2 more
University of Arizona 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808
What this trial is testing

See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

Who this might be right for
Estrogen Receptor Positive Breast Cancer
AHS Cancer Control Alberta 19
Not applicableNo Longer AvailableNCT02142868
What this trial is testing

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

Who this might be right for
Advanced Breast Cancer (Female)
Pfizer
Not applicableEnded earlyNCT00816582
What this trial is testing

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
British Columbia Cancer Agency 17
Next Page